PerioLase Millennium MVP-7 Dental Laser

PerioLase Millennium MVP-7 Dental Laser Technologies All Features:
Procedure-controlled menu
Touchscreen controls
Power meter indicator
Short pulse width

Dental Laser Millennium Technologies Benefits:
Convenient and intuitive operation
Safe for patients and operators
Ideal oral tissue cutting

Achieve immediate profitability and increased patient satisfaction with world’s first and only FDA clearance for True Regeneration – new cementum, new PDL, new alveolar bone! The bone building LANAP protocol with the PerioLase MVP-7 has the power to reverse gum disease with a simple, sutureless procedure developed by GPs for GPs and preferred by patients.
The PerioLase MVP-7, an optimized free-running Nd:YAG laser, is designed specifically to perform the high ROI LANAP and LAPIP periodontitis and peri-implantitis treatment protocols, as well as a range of Value Added Procedures (VAPs) laser applications.
5 days of live-patient training and a 6-month, money back, clinical results guarantee are included.

Specifications:
– Item: PerioLase MVP-7 Dental Laser
– Warranty: 2 years
– Weight: 19.6 kg (43 pounds)
– Power: 6 watts
– Physical Media Source: Nd:YAG
– Dimensions: 27.9 x 41.9 x 62.2 cm (11 x 16.5 x 24.5 inches)
– Dental Applications: Soft And Hard Tissue Applications
– Pulse Energy: 20 – 300 mJ
– Laser Classification: Class 4 Laser
– Operating Voltage: 110 – 120 volts, 200 – 240 volts (Single Phase)
– Available Tips and Sizes: Flexible Fiber Optic Delivery System, 360 µ, 400 µ, 600 µ
– Tip Sterilization Method: Autoclave
– Handpiece Type / Swivel: Anodized Aluminum TrueFlex Three Part Hand Piece
– Control Panel: Touchscreen
– Wavelength: 1,064 nm
– Foot Operation: Yes
– Portable: Yes

Specifications
Manufacturer:  PerioLase Millennium MVP-7 Dental Laser Technologies
Model: Dental laser PerioLase MVP-7

Dental Laser Style: cart
Laser Type: soft & hard tissue
Control type: digital touch screen

Millennium Dental’s Minimally Invasive PerioLase MVP-7 Laser: Not Just for Periodontitis

Jon Suzuki, DDS, PhD, MBA, is a highly regarded leader in the field of dentistry. Currently serving as Professor, Department Chairman, Program Director, Department of Periodontology & Oral Implantology in the Kornberg School of Dentistry at Temple University in Philadelphia, he’s amassed an impressive resume of accomplishments, including the publication of more than 150 papers, chapters, symposia, abstracts, and a textbook in medical technology. A clinician on the pulse of cutting-edge technology, Dr. Suzuki knows a game-changing development when he sees one. He discusses the PerioLase MVP-7 from Millennium Dental.

Q: What do you find particularly exciting now in the field of laser dentistry?

A: The PerioLase MVP-7 Nd:YAG laser for the LANAP protocol offers major benefits in dentistry, especially in the field of periodontics, and it is important for practitioners in all types of practice to keep up with advances in the field. The investment in the PerioLase by our periodontology department is indeed a part of keeping up with the trends in dentistry. I wanted a better-trained faculty and better-trained residents as they go out into the practice community, and this was part of the decision-making process for seeking the PerioLase.

Q: Why does the PerioLase MVP-7 stand out among dental lasers?

A: I believe the primary indication is the FDA clearance for the management and treatment of periodontitis, especially those patients with systemic conditions and diseases—ie, medically compromised patients. This includes patients on blood thinners for the prevention of a second heart attack or second stroke or joint replacement therapy. Using the PerioLase MVP-7 would obviate the need to take these patients off the blood thinners prior to treatment.

Q: Where does the LANAP protocol fit into the trend toward evidence-based medicine?

A: The LANAP treatment is a very well-defined protocol and is evidence-based, with several studies supporting its clinical outcome. FDA approval is primarily for periodontitis, so whether treating a case of early, moderate, or late-stage periodontitis, the LANAP protocol is suitable. It is especially indicated in patients who are medically compromised, medication-influenced, on blood thinners or have any issue of wound healing being hampered.

Q: What has been the response among faculty, students, and patients regarding the LANAP protocol?

A: The reception among faculty and third-year residents using the LANAP protocol in the operating room suite at Temple Episcopal Hospital has been outstanding. As for patients, not only do they like that the LANAP treatment requires fewer visits, but also that there is less postoperative pain and faster healing compared to sutures. Patient reaction has resulted in increased patient treatment acceptance. Ultimately, as the word gets around, there is the potential for more referrals.